Australian scientists have developed the world's most detailed gene map of the human retina, providing new and unprecedented insights into...
Read moreDetailsOphthalmic device manufacturer and distributor Heidelberg Engineering has opened a new Australian support centre in Melbourne. Located at 63-85 Turner...
Read moreDetailsThe Fred Hollows Foundation CEO Mr Ian Wishart has been selected as a finalist for the University of Canberra's (UC)...
Read moreDetailsThe Australasian College of Optical Dispensing (ACOD) has announced a new charity partnership that will see a portion of student...
Read moreDetailsFar North Queensland patients requiring retinal surgery will be spared the travel to metropolitan areas for treatment following the arrival...
Read moreDetailsUS regulators have cleared a new and more convenient method to administer Regeneron Pharmaceuticals' blockbuster macular disease drug, Eylea. On...
Read moreDetailsFollowing a series of controversial news reports, RANZCO has sought to clarify its position on nurses and optometrists performing intravitreal...
Read moreDetailsPioneer in micro-invasive glaucoma surgery (MIGS) Glaukos has announced it will acquire US-based ophthalmic pharmaceutical and medical technology developer Avedro....
Read moreDetailsFive year results from the world's longest-running clinical trial of paediatric contact lens wear has shown CooperVision's MiSight 1 Day...
Read moreDetailsMelbourne-based biotech company Opthea has demonstrated that combination therapy involving its lead drug candidate OPT-302 is superior to standalone Lucentis...
Read moreDetails
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited